Discuss in detail about ADA diabetes guidelines 2026, scoring, classifications, anaesthetic implications and considerations
Reading File
Finding Sources
Finding Sources
Searching PubMed
ADA "Standards of Care" diabetes 2025 2026
Searching the Web
ADA diabetes standards of care 2026 classification guidelines updates
Reading Web Page
https://aladlatam.org/wp-content/uploads/2026/02/standards-o…
Finding Sources
Finding Sources
Searching PubMed
"diabetes mellitus" AND "perioperative" AND "anesthesia" AND "glycemic"
Reading File
Reading File
Reading Article
PMID: 38517760
Reading Web Page
https://aladlatam.org/wp-content/uploads/2026/02/standards-o…
Searching the Web
ADA 2026 standards of care diabetes hospital perioperative anaesthesia GLP-1 insulin management section 16
Finding Sources
Reading Article
PMID: 39890345
This is a comprehensive, current review sourced directly from the ADA Standards of Care in Diabetes — 2026. Here are the key takeaways organised by domain:
Quick Navigation
| Section | Topic |
|---|---|
| 1 | Evidence Grading (A/B/C/E system) |
| 2 | Diagnostic Criteria (glucose, HbA1c, OGTT thresholds) |
| 3 | Classification: T1DM, T2DM, GDM, Other — including T1DM staging table and cancer drug–induced hyperglycaemia |
| 4 | Glycaemic Targets (HbA1c, TIR, preprandial/postprandial) |
| 5 | Pharmacotherapy (GLP-1 RA expansions, SGLT-2i, DPP-4) |
| 6 | Perioperative Goals — two new 2026 recommendations: HbA1c <8% pre-surgery; glucose 100–180 mg/dL intraoperatively |
| 7 | Anaesthetic Implications — airway (cheiroarthropathy), gastroparesis, GLP-1 RA risks, drug management, intraoperative monitoring, regional vs. general anaesthesia |
| 8 | Transplant perioperative diabetes |
| 9 | DKA and HHS — perioperative recognition and management |
| 10 | Summary table of 2026 anaesthesia-relevant changes |
The two most clinically significant 2026 additions for anaesthetists are:
- Pre-elective surgery HbA1c target of <8% (Rec 16.14) — a formal, citable threshold for pre-assessment
- Perioperative glucose target of 100–180 mg/dL (Rec 16.15) — standardising what had previously been institution-dependent practice
This is a shared conversation. Sign in to Orris to start your own chat.